InsidersTradesSigma
Follow the 博瑞医药 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 博瑞医药 has logged 1 reports. Market capitalisation: €14.5bn. The latest transaction was filed on 18 November 2024 (Purchase). Among the most active insiders: 程增江. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
博瑞医药是一家在上海证券交易所上市的医疗保健和制药公司。它专注于创新药物的开发和商业化。